Skip to Main Content

Author Details

Rajarshi Guha
Vertex Pharmaceuticals
2004
142
44
PMIDPaper TitleJournal TitlePublished Year
36737802A look back at a pilot of the citation typing ontology.J Cheminform2023
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
37211605Harnessing Shannon entropy-based descriptors in machine learning models to enhance the prediction accuracy of molecular properties.J Cheminform2023
37391855Improving reproducibility and reusability in the Journal of Cheminformatics.J Cheminform2023
36737802A look back at a pilot of the citation typing ontology.J Cheminform2023
37391855Improving reproducibility and reusability in the Journal of Cheminformatics.J Cheminform2023
37211605Harnessing Shannon entropy-based descriptors in machine learning models to enhance the prediction accuracy of molecular properties.J Cheminform2023
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
35468863Diversifying cheminformatics.J Cheminform2022
35511749A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.Mol Cancer Ther2022
35468863Diversifying cheminformatics.J Cheminform2022
35511749A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.Mol Cancer Ther2022
34229726Reply to "FAIR chemical structure in the Journal of Cheminformatics".J Cheminform2021
34229726Reply to "FAIR chemical structure in the Journal of Cheminformatics".J Cheminform2021
34107377The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.Neoplasia2021
34264955Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.PLoS One2021
33653411What is the role of cheminformatics in a pandemic?J Cheminform2021
33653411What is the role of cheminformatics in a pandemic?J Cheminform2021
34107377The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.Neoplasia2021
34264955Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.PLoS One2021
31498718Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.SLAS Discov2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
32575908Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model.Cancers (Basel)2020
33334024Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer.Cancers (Basel)2020
33430970Learning cheminformatics.J Cheminform2020
33214619Moving targets in drug discovery.Sci Rep2020
31498718Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.SLAS Discov2020
33430970Learning cheminformatics.J Cheminform2020
33334024Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer.Cancers (Basel)2020
33214619Moving targets in drug discovery.Sci Rep2020
32575908Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model.Cancers (Basel)2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
30289729Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.SLAS Technol2019
31748226Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.Sci Transl Med2019
30397176A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma.Clin Cancer Res2019
30353932Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.Hepatology2019
30289729Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.SLAS Technol2019
31291087Nonuniform Crowding Enhances Transport.ACS Nano2019
30979745High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.Clin Cancer Res2019
31281945Journal of Cheminformatics, ORCID, and GitHub.J Cheminform2019
31133849The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics.Front Pharmacol2019
31446060High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.Papillomavirus Res2019
30848454High-Throughput Screening for Drug Combinations.Methods Mol Biol2019
31395684Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.Mol Cancer Ther2019
30719588Implementing cheminformatics.J Cheminform2019
31515284A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.Mol Pharmacol2019
31532656Scaffold-Based Analytics: Enabling Hit-to-Lead Decisions by Visualizing Chemical Series Linked across Large Datasets.J Chem Inf Model2019
31748226Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.Sci Transl Med2019
31532656Scaffold-Based Analytics: Enabling Hit-to-Lead Decisions by Visualizing Chemical Series Linked across Large Datasets.J Chem Inf Model2019
31291087Nonuniform Crowding Enhances Transport.ACS Nano2019
  • 1 - 50 of 284

Recommended Authors

European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2019
Number of shared co-authors 4
The University of New Mexico School of Medicine
Career Start Year 2016
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Center for Drug Evaluations and Research (CDER)
Career Start Year 2013
Number of shared co-authors 1
Washington University in St. Louis
Career Start Year 2012
Number of shared co-authors 1
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Institute for Neurodegenerative Diseases, University of California san francisco
Career Start Year 2007
Number of shared co-authors 2
University of Helsinki
Career Start Year 2007
Number of shared co-authors 6
National Center for Biotechnology Information, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 5
The Manchester Institute of Biotechnology, The University of Manchester
Career Start Year 2004
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 11
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Swedish Toxicology Sciences Research Center, Karolinska Institutet
Career Start Year 2002
Number of shared co-authors 4
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2002
Number of shared co-authors 7
Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra
Career Start Year 2001
Number of shared co-authors 4
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 7
Ruder Boskovic Institute
Career Start Year 1998
Number of shared co-authors 0
INSERM
Career Start Year 1998
Number of shared co-authors 0
Broad Institute
Career Start Year 1997
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 10
Universitat Tubingen, Institut fur Arbeitsmedizin
Career Start Year 1996
Number of shared co-authors 6
University of Dundee
Career Start Year 1995
Number of shared co-authors 8
National Center for Advancing Translational Science, 9800 Medical Center Drive
Career Start Year 1993
Number of shared co-authors 8
Merck Research Laboratories, Merck & Co.
Career Start Year 1991
Number of shared co-authors 3
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 13
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 5
Lexicon Pharmaceuticals
Career Start Year 1983
Number of shared co-authors 1
Stanford University
Career Start Year 1982
Number of shared co-authors 4
Lilly Research Laboratories
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 45
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 35
National Center for Advancing Translational Sciences
Co-authored papers 19
Co-authored papers 14
Maastricht University
Co-authored papers 13
Co-authored papers 12
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 10
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 10
Indiana University Bloomington
Co-authored papers 9
Co-authored papers 8
Institute for Data Science and Computing, University of Miami
Co-authored papers 7
Co-authored papers 7
Institute for Inorganic and Analytical Chemistry, Friedrich Schiller University Jena
Co-authored papers 6
St. George's University Medical School
Co-authored papers 6
Expert Systems Inc.
Co-authored papers 5
National Center for Advancing Translational Sciences
Co-authored papers 5
Co-authored papers 4
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 4
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 4
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
University of New Mexico School of Medicine
Co-authored papers 4
Dana-Farber Cancer Institute
Co-authored papers 4
Co-authored papers 4
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 3
Co-authored papers 3